Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2019; 16(3):450-460. doi:10.7150/ijms.29935 This issue Cite

Review

Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations

Mardiaty Iryani Abdullah1,5, Sarni Mat Junit1, Khoon Leong Ng2, Jaime Jacqueline Jayapalan3, Barani Karikalan4, Onn Haji Hashim1,3✉

1. Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
2. Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
3. University of Malaya Centre for Proteomics Research, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
4. Perdana University, Jalan MAEPS Perdana, Serdang 43400, Selangor, Malaysia.
5. Department of Biomedical Science, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, 25200 Kuantan, Pahang, Malaysia.

✉ Corresponding author: Professor Dr. Onn Haji Hashim, Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. Tel.: +603-79674955; Fax: +603-79674957. Email address: onnhashimedu.my

Citation:
Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci 2019; 16(3):450-460. doi:10.7150/ijms.29935. https://www.medsci.org/v16p0450.htm
Other styles

File import instruction

Abstract

Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.

Keywords: papillary thyroid cancer, molecular alteration, genetic signature, biomarker, diagnostics

Citation styles

APA
Abdullah, M.I., Junit, S.M., Ng, K.L., Jayapalan, J.J., Karikalan, B., Hashim, O.H. (2019). Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. International Journal of Medical Sciences, 16(3), 450-460. https://doi.org/10.7150/ijms.29935.

ACS
Abdullah, M.I.; Junit, S.M.; Ng, K.L.; Jayapalan, J.J.; Karikalan, B.; Hashim, O.H. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int. J. Med. Sci. 2019, 16 (3), 450-460. DOI: 10.7150/ijms.29935.

NLM
Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci 2019; 16(3):450-460. doi:10.7150/ijms.29935. https://www.medsci.org/v16p0450.htm

CSE
Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. 2019. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci. 16(3):450-460.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use